UNSPSC 51283908: Sulfadiazine

This classification denotes a sulfonamide anti-infective agent with the molecular formula C10H10N4O2S, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 0N7609K889, chemically known as trisulfapyrimidine, oral suspension but generally known as sulfadiazine, which bears US NIH Compound Identifier 5215. European Medicines Agency schedules Sulfadiazine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB10695MIG.

UNSPSC 51283908 Sulfadiazine is a Commodity code that nominally describes a specific sulfonamide antibiotic, yet recent state and local opportunities tagged under this code reflect much broader pharmaceutical and medical supply procurement — including naloxone distribution systems, generic multi-source pharmaceuticals through cooperative purchasing, direct-to-manufacturer prescription programs, and emergency medical and first aid supplies for fire rescue operations. The issuing bodies span county health departments, state health and human services commissions, municipal fire departments, and multistate cooperative purchasing alliances. The scope of work actually being solicited includes annual naloxone and drug deactivation system procurement for community health initiatives, establishment of contracts for generic pharmaceuticals and OTC products distributed through authorized wholesalers, pharmacy benefit program modernization through direct manufacturer relationships, and bulk medical supply contracting for emergency response units.

Activity occurs across multiple states and regions, with recent opportunities posted from Florida (Seminole County), Texas (HHS Commission), Minnesota (MMCAP cooperative, serving Minnesota and Oregon participants), and Florida (City of Tampa). Representative recent solicitations include Seminole County's IFB60459723LAS (posted June 30, 2026), seeking 1,900 units of naloxone and 800 safe drug deactivation systems annually with a response deadline of July 26, 2023; the City of Tampa's Bid 26P00145 (posted March 25, 2026), for 169 line items of medical and first aid supplies supporting the Tampa Fire Department Rescue Division, with an estimated contract value of $700,000 and a response deadline of March 13, 2026, designated as a sheltered market opportunity for certified Small Local Business Enterprises with a 5 percent bid discount; and the Minnesota Multistate Cooperative Purchasing Alliance's RFP S1070000015802 (posted January 20, 2026), establishing multiple contracts for generic pharmaceuticals and OTC products, with a response deadline of March 26, 2026. The Texas HHS Commission issued RFI HHS0017013 (posted April 3, 2026) to gather market intelligence on direct-to-manufacturer prescription fulfillment capabilities rather than issue a binding solicitation.